What is known and objectives Most antineoplastic drugs are highly toxic and have low
therapeutic indexes, which can result in drug‐related problems. In this context, pharmacist …

Introduction Although many oncology pharmacists are embedded members within the
healthcare team, data documenting their contributions to optimal patient outcomes are …

Although oncology pharmacists have been involved in the care of cancer patients for over
50 years, the role of the oncology pharmacist continues to expand. Initially, pharmacists …

Purpose Published literature describing the effectiveness of outpatient oncology services
delivered by clinical pharmacists is summarized. Methods Peer-reviewed articles on studies …

PURPOSE To provide standards for medically integrated dispensing of oral anticancer
drugs and supportive care medications. METHODS An Expert Panel was formed, and a …

PROBLEM IDENTIFICATION: This systematic review compared the efficacy of interventions
to usual care on adherence to oral anticancer regimens. LITERATURE SEARCH: Embase® …

PURPOSE: This evidence-based guideline intends to support patients, clinicians, and others
regarding interventions and processes to support patient adherence to oral anticancer …

Domains of Structured Oral Anticancer Medication Programs: A Scoping Review - PMC Back
to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …

Purpose: To determine the amount of time elapsed between prescriber order and patient
receiving oral anticancer medication. Patients and Methods: Adult patients with a diagnosis …

Purpose To describe the outcomes of a pharmacist-led multi-center, collaborative patient
education and proactive adverse event management program in a community-based …